- ICH GCP
- EU: s kliniska prövningsregister
Senaste försöken
EudraCT Number: 2006-000476-33 | Sponsor Protocol Number: GC-SU-2006 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: Johannes-Gutenberg-Universität Mainz, I. Medizinische Klinik und Poliklinik | |||||||||||||
Full Title: An open-label, multicenter phase II trial of Sunitinib for patients with chemo-refractory metastatic gastric cancer | |||||||||||||
Medical condition: Chemorefractory metastatic adenocarcinoma of stomach, esophagogastric junction and lower esophagus (Barrett carcinoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004882-32 | Sponsor Protocol Number: BY1023/NL511 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: ALTANA Pharma bv | |||||||||||||
Full Title: Evaluation of clinical endpoints for treatment-induced changes in GERD-related symptoms | |||||||||||||
Medical condition: gastroesophageal reflux disease (GERD) or Non Erosive Reflux Disease (NERD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002052-15 | Sponsor Protocol Number: SPD490-301 | Start Date: 2006-11-20 | ||||||
Sponsor Name: Shire | ||||||||
Full Title: An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients with Anaemia Asso... | ||||||||
Medical condition: Anaemia in Chronic Kidney Disease (CKD) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) AT (Prematurely Ended) FR (Completed) DE (Prematurely Ended) IT (Prematurely Ended) LT (Prematurely Ended) LV (Prematurely Ended) HU (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-002403-13 | Sponsor Protocol Number: Ularitide-1502 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: PDL BioPharma Inc | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blinded, Placebo-controlled Study of Ularitide in the Treatment of Subjects with Acute Decompensated Heart Failure | |||||||||||||
Medical condition: Acute decompensated heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) LT (Prematurely Ended) AT (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000687-89 | Sponsor Protocol Number: ICR-CTSU/2008/10018 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: Institute of Cancer Research | |||||||||||||
Full Title: A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder | |||||||||||||
Medical condition: Non-muscle Invasive Transitional cell Carcinoma of the Bladder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004749-40 | Sponsor Protocol Number: PEDMet 2006-1 | Start Date: 2006-11-20 | ||||||
Sponsor Name: Pediatrics | ||||||||
Full Title: Glucose metabolism in patients with neurological/neuromuscular diseases. | ||||||||
Medical condition: Patients with neurological/neuromuscular diseases | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||
Trial protocol: BE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004722-82 | Sponsor Protocol Number: CSTI571E2204 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: Novartis Pharma Services AG | |||||||||||||
Full Title: An exploratory study of the effects of Imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to T... | |||||||||||||
Medical condition: Seasonal Allergic Rhinitis (sensitivity to Timothy grass pollen) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004516-51 | Sponsor Protocol Number: GEN112 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: Genmab A/S | |||||||||||||
Full Title: A multicentre open-label, dose-escalation, trial of zanolimumab in combination with CHOP chemotherapy in subjects with CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement | |||||||||||||
Medical condition: CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) DE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004735-30 | Sponsor Protocol Number: IH 003 | Start Date: 2006-11-20 | |||||||||||
Sponsor Name: Ineos Healthcare Ltd | |||||||||||||
Full Title: An open label, dose-ranging study to establish the tolerability of Alpharen™ in haemodialysis subjects with hyperphosphataemia. | |||||||||||||
Medical condition: Hyperphosphataemia in haemodialysis subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003409-18 | Sponsor Protocol Number: RRC-2/3-2006 | Start Date: 2006-11-20 | ||||||
Sponsor Name: Sahlgrenska University Hospital, Östra | ||||||||
Full Title: An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Ch... | ||||||||
Medical condition: chronic hepatitis C (CHC) virus infection genotype 2 or 3 who responded during (i.e. had HCV-RNA | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: SE (Ongoing) DK (Completed) FI (Completed) | ||||||||
Trial results: (No results available) |